Within T cells, CD8+ cytotoxic T cells remain the most potent mediators of anti-tumor immunity, and a response directed by either CD4+ T helper 1 (Th1) cells or Th17 cells promote CD8+ effector T cell responses (Martin-Orozco et al., 2009). The gene discussed is CD8A; the disease is neoplasm.